IAPP

Roberts A.N., Leighton B., Todd J.A., Cockburn D., Schofield P.N., Sutton R., Holt S., Boyd Y., Day A.J., Foot E.A., Willis A.C., Reid K.B.M., Cooper G.J.S.,

Proc. Natl. Acad. Sci. U.S.A. 86:9662-9666(1989)

Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin

Hubbard J.A.M., Martin S.R., Chaplin L.C., Bose C., Kelly S.M., Price N.C.,

Biochem. J. 275:785-788(1991)

Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study

Mascioni A., Porcelli F., Ilangovan U., Ramamoorthy A., Veglia G.,

Biopolymers 69:29-41(2003)

Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism

Shen Y., Joachimiak A., Rosner M.R., Tang W.-J.,

Nature 443:870-874(2006)

Dynamic alpha-helix structure of micelle-bound human amylin

Patil S.M., Xu S., Sheftic S.R., Alexandrescu A.T.,

J. Biol. Chem. 284:11982-11991(2009)

Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process

Wiltzius J.J., Sievers S.A., Sawaya M.R., Eisenberg D.,

Protein Sci. 18:1521-1530(2009)

Missense mutation of amylin gene (S20G) in Japanese NIDDM patients

Sakagashira S., Sanke T., Hanabusa T., Shimomura H., Ohagi S., Kumagaye K.Y., Nakajima K., Nanjo K.,

Diabetes 45:1279-1281(1996)

Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients

Chuang L.M., Lee K.C., Huang C.N., Wu H.P., Tai T.Y., Lin B.J.,

Diabetologia 41:1250-1251(1998)

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B.,

Proc. Natl. Acad. Sci. U.S.A. 84:8628-8632(1987)

Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species

Betsholtz C., Christmansson L., Engstroem U., Rorsman F., Svensson V., Johnson K.H., Westermark P.,

FEBS Lett. 251:261-264(1989)

Isolation and identification of islet amyloid polypeptide in normal human pancreas

Nakazato M., Asai J., Miyazato M., Matsukura S., Kangawa K., Matsuo H.,

Regul. Pept. 31:179-186(1990)

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas

Westermark P., Wernstedt C., Wilander E., Sletten K.,

Biochem. Biophys. Res. Commun. 140:827-831(1986)

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

Westermark P., Wernstedt C., Wilander E., Hayden D.W., O'Brien T.D., Johnson K.H.,

Proc. Natl. Acad. Sci. U.S.A. 84:3881-3885(1987)

The complete islet amyloid polypeptide precursor is encoded by two exons.

Mosselman S., Hoeppener J.W.M., Lips C.J.M., Jansz H.S.,

FEBS Lett. 247:154-158(1989)

Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history.

Nishi M., Sanke T., Seino S., Eddy R.L., Fan Y.-S., Byers M.G., Shows T.B., Bell G.I., Steiner D.F.,

Mol. Endocrinol. 3:1775-1781(1989)

An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.

Sanke T., Bell G.I., Sample C., Rubenstein A.H., Steiner D.F.,

J. Biol. Chem. 263:17243-17246(1988)

The human islet amyloid polypeptide (IAPP) gene. Organization, chromosomal localization and functional identification of a promoter region.

Christmanson L., Rorsman F., Stenman G., Westermark P., Betsholtz C.,

FEBS Lett. 267:160-166(1990)

Islet amyloid polypeptide: structure and upstream sequences of the IAPP gene in rat and man.

van Mansfeld A.D.M., Mosselman S., Hoeppener J.W.M., Zandberg J., van Teeffelen H.A.A.M., Baas P.D., Lips C.J.M., Jansz H.S.,

Biochim. Biophys. Acta 1087:235-240(1990)

Characterization of the human islet amyloid polypeptide/amylin gene transcripts: identification of a new polyadenylation site.

Hoeppener J.W.M., Oosterwijk C., Visser-Vernooy H.J., Lips C.J.M., Jansz H.S.,

Biochem. Biophys. Res. Commun. 189:1569-1577(1992)

Cloning and expression of human islet amyloid polypeptide in cultured cells.

Bhattacharya S., Naveena Lavanya Latha J., Kumresan R., Singh S.,

Biochem. Biophys. Res. Commun. 356:622-628(2007)

Islet amyloid polypeptide: identification and chromosomal localization of the human gene.

Mosselman S., Hoeppener J.W.M., Zandberg J., van Mansfeld A.D.M., Geurts van Kessel A.H.M., Lips C.J.M., Jansz H.S.,

FEBS Lett. 239:227-232(1988)

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B.,

Proc. Natl. Acad. Sci. U.S.A. 84:8628-8632(1987)

Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species.

Betsholtz C., Christmansson L., Engstroem U., Rorsman F., Svensson V., Johnson K.H., Westermark P.,

FEBS Lett. 251:261-264(1989)

Isolation and identification of islet amyloid polypeptide in normal human pancreas.

Nakazato M., Asai J., Miyazato M., Matsukura S., Kangawa K., Matsuo H.,

Regul. Pept. 31:179-186(1990)

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

Westermark P., Wernstedt C., Wilander E., Sletten K.,

Biochem. Biophys. Res. Commun. 140:827-831(1986)

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

Westermark P., Wernstedt C., Wilander E., Hayden D.W., O'Brien T.D., Johnson K.H.,

Proc. Natl. Acad. Sci. U.S.A. 84:3881-3885(1987)

Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.

Roberts A.N., Leighton B., Todd J.A., Cockburn D., Schofield P.N., Sutton R., Holt S., Boyd Y., Day A.J., Foot E.A., Willis A.C., Reid K.B.M., Cooper G.J.S.,

Proc. Natl. Acad. Sci. U.S.A. 86:9662-9666(1989)

Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin.

Hubbard J.A.M., Martin S.R., Chaplin L.C., Bose C., Kelly S.M., Price N.C.,

Biochem. J. 275:785-788(1991)

Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study.

Mascioni A., Porcelli F., Ilangovan U., Ramamoorthy A., Veglia G.,

Biopolymers 69:29-41(2003)

Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.

Shen Y., Joachimiak A., Rosner M.R., Tang W.-J.,

Nature 443:870-874(2006)

Dynamic alpha-helix structure of micelle-bound human amylin.

Patil S.M., Xu S., Sheftic S.R., Alexandrescu A.T.,

J. Biol. Chem. 284:11982-11991(2009)

Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.

Wiltzius J.J., Sievers S.A., Sawaya M.R., Eisenberg D.,

Protein Sci. 18:1521-1530(2009)

Missense mutation of amylin gene (S20G) in Japanese NIDDM patients.

Sakagashira S., Sanke T., Hanabusa T., Shimomura H., Ohagi S., Kumagaye K.Y., Nakajima K., Nanjo K.,

Diabetes 45:1279-1281(1996)

Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients.

Chuang L.M., Lee K.C., Huang C.N., Wu H.P., Tai T.Y., Lin B.J.,

Diabetologia 41:1250-1251(1998)

A stop-codon mutation in the BRI gene associated with familial British dementia.

Vidal R., Frangione B., Rostagno A., Mead S., Revesz T., Plant G., Ghiso J.,

Nature 399:776-781(1999)

Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid.

Haeggqvist B., Naeslund J., Sletten K., Westermark G.T., Mucchiano G., Tjernberg L.O., Nordstedt C., Engstroem U., Westermark P.,

Proc. Natl. Acad. Sci. U.S.A. 96:8669-8674(1999)

Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.

McLaurin J., Franklin T., Zhang X., Deng J., Fraser P.E.,

Eur J Biochem 266:1101-1110(1999)

The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels.

Lee S.C., Hashim Y., Li J.K., Ko G.T., Critchley J.A., Cockram C.S., Chan J.C.,

Clin Endocrinol (Oxf) 54:541-546(2001)

A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene.

Benson M.D., Liepnieks J.J., Yazaki M., Yamashita T., Hamidi Asl K., Guenther B., Kluve-Beckerman B.,

Genomics 72:272-277(2001)

Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis.

Bergstrom J., Murphy C., Eulitz M., Weiss D.T., Westermark G.T., Solomon A., Westermark P.,

Biochem Biophys Res Commun 285:903-908(2001)

Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.

Kapurniotu A., Schmauder A., Tenidis K.,

J Mol Biol 315:339-350(2002)

Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding.

Chakrabarti S.K., James J.C., Mirmira R.G.,

J Biol Chem 277:13286-13293(2002)

Binding of serum amyloid P-component (SAP) by amyloid fibrils.

Pepys M.B., Dyck R.F., de Beer F.C., Skinner M., Cohen A.S.,

Clin Exp Immunol 38:284-293(1979)

Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylin.

Kraemer R.R., Acevedo E.O., Synovitz L.B., Durand R.J., Johnson L.G., Petrella E., Fineman M.S., Gimpel T., Castracane V.D.,

Metabolism 51:657-663(2002)

Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus.

Feldman D.S., Zamah A.M., Pierce K.L., Miller W.E., Kelly F., Rapacciuolo A., Rockman H.A., Koch W.J., Luttrell L.M.,

J Biol Chem 277:28631-28640(2002)

Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide.

Geisler J.G., Zawalich W., Zawalich K., Lakey J.R., Stukenbrok H., Milici A.J., Soeller W.C.,

Diabetes 51:2158-2169(2002)

Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants.

Wenzel-Seifert K., Liu H.Y., Seifert R.,

Biochem Pharmacol 64:9-20(2002)

Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus.

Hayden M.R.,

JOP 3:126-138(2002)

Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.

Rijkers D.T., Hoppener J.W., Posthuma G., Lips C.J., Liskamp R.M.,

Chemistry 8:4285-4291(2002)

Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide.

Mazor Y., Gilead S., Benhar I., Gazit E.,

J Mol Biol 322:1013-1024(2002)

Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells.

Zhang S., Liu J., MacGibbon G., Dragunow M., Cooper G.J.,

J Mol Biol 324:271-285(2002)

Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.

Hull R.L., Andrikopoulos S., Verchere C.B., Vidal J., Wang F., Cnop M., Prigeon R.L., Kahn S.E.,

Diabetes 52:372-379(2003)

Polymorphism in intron 2 of islet amyloid polypeptide gene is associated with lower low-density lipoprotein cholesterol in nondiabetic subjects and in type 2 diabetic patients.

Rojas I., Gomis R., Casals E., Quinto L.I., Franco C., Novials A.,

Endocrine 19:185-189(2002)

Full-length rat amylin forms fibrils following substitution of single residues from human amylin.

Green J., Goldsbury C., Mini T., Sunderji S., Frey P., Kistler J., Cooper G., Aebi U.,

J Mol Biol 326:1147-1156(2003)

Human amylin actions on rat cholinergic basal forebrain neurons: antagonism of beta-amyloid effects.

Jhamandas J.H., Harris K.H., Cho C., Fu W., MacTavish D.,

J Neurophysiol 89:2923-2930(2003)

Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori.

Poa N.R., Cooper G.J., Edgar P.F.,

Diabetologia 46:574-578(2003)

Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes.

Powell D.S., Maksoud H., Charge S.B., Moffitt J.H., Desai M., Da Silva Fihlo R.L., Hattersley A.T., Stratton I.M., Matthews D.R., Levy J.C., Clark A.,

Diabetes Res Clin Pract 60:105-110(2003)

S20G mutation of the amylin gene is associated with a lower body mass index in Korean type 2 diabetic patients.

Cho Y.M., Kim M., Park K.S., Kim S.Y., Lee H.K.,

Diabetes Res Clin Pract 60:125-129(2003)

Isolation and partial characterization of SAA-an amyloid-related protein from human serum.

Rosenthal C.J., Franklin E.C., Frangione B., Greenspan J.,

J Immunol 116:1415-1418(1976)

Nasu Hakola disease: a report of the first two cases in Bolivia.

Molina-Monasterios M.C., Molina-Abecia H.,

Rev Neurol 36:837-840(2003)

The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29.

Zanuy D., Nussinov R.,

J Mol Biol 329:565-584(2003)

Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.

Zhang J.Y., Nawoschik S., Kowal D., Smith D., Spangler T., Ochalski R., Schechter L., Dunlop J.,

Eur J Pharmacol 472:33-38(2003)

Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.

Gorn A.H., Lin H.Y., Yamin M., Auron P.E., Flannery M.R., Tapp D.R., Manning C.A., Lodish H.F., Krane S.M., Goldring S.R.,

J. Clin. Invest. 90:1726-1735(1992)

Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1.

Zhang S., Liu J., Dragunow M., Cooper G.J.,

J Biol Chem 278:52810-52819(2003)

Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes.

Zhao H.L., Lai F.M., Tong P.C., Zhong D.R., Yang D., Tomlinson B., Chan J.C.,

Diabetes 52:2759-2766(2003)

Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors.

Rotondo F., Vidal S., Bell D., Horvath E., Kovacs K., Scheithauer B.W., Lloyd R.V.,

Acta Histochem 105:303-307(2003)

The mechanism of insulin action on islet amyloid polypeptide fiber formation.

Larson J.L., Miranker A.D.,

J Mol Biol 335:221-231(2004)

Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP).

Lopes D.H., Colin C., Degaki T.L., de Sousa A.C., Vieira M.N., Sebollela A., Martinez A.M., Bloch C. Jr., Ferreira S.T., Sogayar M.C.,

J Biol Chem 279:42803-42810(2004)

Phospholipid catalysis of diabetic amyloid assembly.

Knight J.D., Miranker A.D.,

J Mol Biol 341:1175-1187(2004)

Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.

Green J.D., Kreplak L., Goldsbury C., Li Blatter X., Stolz M., Cooper G.S., Seelig A., Kistler J., Aebi U.,

J Mol Biol 342:877-887(2004)

Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers.

Sparr E., Engel M.F., Sakharov D.V., Sprong M., Jacobs J., de Kruijff B., Hoppener J.W., Killian J.A.,

FEBS Lett 577:117-120(2004)

Atomic force microscopy study of human amylin (20-29) fibrils.

Sedman V.L., Allen S., Chan W.C., Davies M.C., Roberts C.J., Tendler S.J., Williams P.M.,

Protein Pept Lett 12:79-83(2005)

Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin.

Balali-Mood K., Ashley R.H., Hauss T., Bradshaw J.P.,

FEBS Lett 579:1143-1148(2005)

Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water.

Colombo G., Daidone I., Gazit E., Amadei A., Di Nola A.,

Proteins 59:519-527(2005)

The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin.

Kajava A.V., Aebi U., Steven A.C.,

J Mol Biol 348:247-252(2005)

Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis.

Esapa C., Moffitt J.H., Novials A., McNamara C.M., Levy J.C., Laakso M., Gomis R., Clark A.,

Biochim Biophys Acta 1740:74-78(2005)

Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?

Westermark P., Andersson A., Westermark G.T.,

Curr Diab Rep 5:184-188(2005)

Senile seminal vesicle amyloid is derived from semenogelin I.

Linke R.P., Joswig R., Murphy C.L., Wang S., Zhou H., Gross U., Rocken C., Westermark P., Weiss D.T., Solomon A.,

J Lab Clin Med 145:187-193(2005)

Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide.

Hull R.L., Shen Z.P., Watts M.R., Kodama K., Carr D.B., Utzschneider K.M., Zraika S., Wang F., Kahn S.E.,

Diabetes 54:2235-2244(2005)

Lipid membranes modulate the structure of islet amyloid polypeptide.

Jayasinghe S.A., Langen R.,

Biochemistry 44:12113-12119(2005)

Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.

Lin C.Y., Gurlo T., Haataja L., Hsueh W.A., Butler P.C.,

J Clin Endocrinol Metab 90:6678-6686(2005)

Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?

Abedini A., Raleigh D.P.,

J Mol Biol 355:274-281(2006)

The role of His-18 in amyloid formation by human islet amyloid polypeptide.

Abedini A., Raleigh D.P.,

Biochemistry 44:16284-16291(2005)

Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.

Engel M.F., Yigittop H., Elgersma R.C., Rijkers D.T., Liskamp R.M., de Kruijff B., Hoppener J.W., Antoinette Killian J.,

J Mol Biol 356:783-789(2006)

Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.

Matveyenko A.V., Butler P.C.,

Diabetes 55:2106-2114(2006)

Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.

Abedini A., Tracz S.M., Cho J.H., Raleigh D.P.,

Biochemistry 45:9228-9237(2006)

Amylin S20G mutation in Mexican population.

Garcia-Gonzalez C.L., Montoya-Fuentes H., Padilla-Rosas M., Sanchez-Corona J.,

Diabetes Res Clin Pract 76:146-148(2007)

Direct detection of transient alpha-helical states in islet amyloid polypeptide.

Williamson J.A., Miranker A.D.,

Protein Sci 16:110-117(2007)

The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain.

Levy M., Garmy N., Gazit E., Fantini J.,

FEBS J 273:5724-5735(2006)

Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats.

Novials A., Rodriguez-Manas L., Chico A., El Assar M., Casas S., Gomis R.,

J Clin Endocrinol Metab 92:1446-1450(2007)

Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.

Lin C.Y., Gurlo T., Kayed R., Butler A.E., Haataja L., Glabe C.G., Butler P.C.,

Diabetes 56:1324-1332(2007)

High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.

Huang C.J., Lin C.Y., Haataja L., Gurlo T., Butler A.E., Rizza R.A., Butler P.C.,

Diabetes 56:2016-2027(2007)

Amylin deposition in the kidney of patients with diabetic nephropathy.

Gong W., Liu Z.H., Zeng C.H., Peng A., Chen H.P., Zhou H., Li L.S.,

Kidney Int 72:213-218(2007)

Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis.

Casas S., Gomis R., Gribble F.M., Altirriba J., Knuutila S., Novials A.,

Diabetes 56:2284-2294(2007)

Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy.

Lopes D.H., Meister A., Gohlke A., Hauser A., Blume A., Winter R.,

Biophys J 93:3132-3141(2007)

A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor.

Abedini A., Meng F., Raleigh D.P.,

J Am Chem Soc 129:11300-11301(2007)

Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.

Hull R.L., Zraika S., Udayasankar J., Kisilevsky R., Szarek W.A., Wight T.N., Kahn S.E.,

Am J Physiol Cell Physiol 293:C1586-93(2007)

Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide.

Huang C.J., Haataja L., Gurlo T., Butler A.E., Wu X., Soeller W.C., Butler P.C.,

Am J Physiol Endocrinol Metab 293:E1656-62(2007)

Beta-amyloid peptides 1-40betaA and 25-35betaA suppress human amylin-mediated death of RINm5F islet beta-cells with distinct actions on fibril formation.

Bai J.Z.,

Cell Biol Int 32:447-455(2008)

Atrial amyloid deposits in the failing human heart display both atrial and brain natriuretic peptide-like immunoreactivity.

Pucci A., Wharton J., Arbustini E., Grasso M., Diegoli M., Needleman P., Vigano M., Polak J.M.,

J Pathol 165:235-241(1991)

Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Engel M.F., Khemtemourian L., Kleijer C.C., Meeldijk H.J., Jacobs J., Verkleij A.J., de Kruijff B., Killian J.A., Hoppener J.W.,

Proc Natl Acad Sci U S A 105:6033-6038(2008)

Leukocyte chemotactic factor 2: A novel renal amyloid protein.

Benson M.D., James S., Scott K., Liepnieks J.J., Kluve-Beckerman B.,

Kidney Int 74:218-222(2008)

Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus.

Khemtemourian L., Killian J.A., Hoppener J.W., Engel M.F.,

Exp Diabetes Res 2008:421287-421287(2008)

Odontogenic ameloblast-associated protein nature of the amyloid found in calcifying epithelial odontogenic tumors and unerupted tooth follicles.

Murphy C.L., Kestler D.P., Foster J.S., Wang S., Macy S.D., Kennel S.J., Carlson E.R., Hudson J., Weiss D.T., Solomon A.,

Amyloid 15:89-95(2008)

Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures.

Lim Y.A., Ittner L.M., Lim Y.L., Gotz J.,

FEBS Lett 582:2188-2194(2008)

Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin.

Maury C.P.,

J Clin Invest 87:1195-1199(1991)

Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.

Hoppener J.W., Jacobs H.M., Wierup N., Sotthewes G., Sprong M., de Vos P., Berger R., Sundler F., Ahren B.,

Exp Diabetes Res 2008:697035-697035(2008)

Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin).

Wiltzius J.J., Sievers S.A., Sawaya M.R., Cascio D., Popov D., Riekel C., Eisenberg D.,

Protein Sci 17:1467-1474(2008)

Dissociation of heterotrimeric g proteins in cells.

Lambert N.A.,

Sci Signal 1:re5-re5(2008)

Disturbed alpha-cell function in mice with beta-cell specific overexpression of human islet amyloid polypeptide.

Ahren B., Sorhede Winzell M.,

Exp Diabetes Res 2008:304513-304513(2008)

[Role of amylin in glucose homeostasis and its perspective use in diabetes management].

Otto-Buczkowska E., Mazur-Dworzecka U., Dworzecki T.,

Przegl Lek 65:135-139(2008)

Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state.

Yonemoto I.T., Kroon G.J., Dyson H.J., Balch W.E., Kelly J.W.,

Biochemistry 47:9900-9910(2008)

Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4.

Casas S., Novials A., Reimann F., Gomis R., Gribble F.M.,

Diabetologia 51:2252-2262(2008)

Higher islet amyloid load in men than in women with type 2 diabetes mellitus.

Zhao H.L., Sui Y., Guan J., He L., Lai F.M., Zhong D.R., Yang D., Baum L., Tong P.C., Tomlinson B., Chan J.C.,

Pancreas 37:e68-73(2008)

Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy.

Nanga R.P., Brender J.R., Xu J., Veglia G., Ramamoorthy A.,

Biochemistry 47:12689-12697(2008)

A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.

Brender J.R., Hartman K., Reid K.R., Kennedy R.T., Ramamoorthy A.,

Biochemistry 47:12680-12688(2008)

Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets.

Udayasankar J., Kodama K., Hull R.L., Zraika S., Aston-Mourney K., Subramanian S.L., Tong J., Faulenbach M.V., Vidal J., Kahn S.E.,

Diabetologia 52:145-153(2009)

Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.

Wei L., Jiang P., Yau Y.H., Summer H., Shochat S.G., Mu Y., Pervushin K.,

Biochemistry 48:2368-2376(2009)

Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis.

Zraika S., Hull R.L., Udayasankar J., Aston-Mourney K., Subramanian S.L., Kisilevsky R., Szarek W.A., Kahn S.E.,

Diabetologia 52:626-635(2009)

Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress.

Matveyenko A.V., Gurlo T., Daval M., Butler A.E., Butler P.C.,

Diabetes 58:906-916(2009)

Increased secretion of amylin in women with polycystic ovary syndrome.

James S., Moralez J., Nagamani M.,

Fertil Steril 94:211-215(2010)

Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution.

Shim S.H., Gupta R., Ling Y.L., Strasfeld D.B., Raleigh D.P., Zanni M.T.,

Proc Natl Acad Sci U S A 106:6614-6619(2009)

Conformation preorganization: effects of S20G mutation on the structure of human islet amyloid polypeptide segment.

Xu W., Jiang P., Mu Y.,

J Phys Chem B 113:7308-7314(2009)

Mutations in IAPP and NEUROG3 genes are not a common cause of permanent neonatal/infancy/childhood-onset diabetes.

Nocerino V., Colombo C., Bonfanti R., Iafusco D., Barbetti F.,

Diabet Med 26:660-661(2009)

Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status.

Caminos J.E., Bravo S.B., Garces M.F., Gonzalez C.R., Cepeda L.A., Gonzalez A.C., Nogueiras R., Gallego R., Garcia-Caballero T., Cordido F., Lopez M., Dieguez C.,

Histol Histopathol 24:979-990(2009)

Mutations in MAFA and IAPP are not a common cause of monogenic diabetes.

Garin I., Martinez R., de las Heras J., Perez-Nanclares G., Castano L., Perez de Nanclares G., Abellan M., Espiga J., Boronat M., Galicia I., Lamas, Lopez-Capape M., Unanue G., Fernandez C., Sobradillo B., Rivas F., Leiva I., Prieto J., Gomez-Gila A.,

Diabet Med 26:746-748(2009)

Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.

Yoshida T., Kato K., Yokoi K., Oguri M., Watanabe S., Metoki N., Yoshida H., Satoh K., Aoyagi Y., Nishigaki Y., Nozawa Y., Yamada Y.,

Int J Mol Med 24:233-246(2009)

Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts.

Wakabayashi M., Matsuzaki K.,

FEBS Lett 583:2854-2858(2009)

Molecular mechanisms for protein-encoded inheritance.

Wiltzius J.J., Landau M., Nelson R., Sawaya M.R., Apostol M.I., Goldschmidt L., Soriaga A.B., Cascio D., Rajashankar K., Eisenberg D.,

Nat Struct Mol Biol 16:973-978(2009)

Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes.

Cho W.J., Trikha S., Jeremic A.M.,

J Mol Biol 393:765-775(2009)

Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice.

Aitken J.F., Loomes K.M., Scott D.W., Reddy S., Phillips A.R., Prijic G., Fernando C., Zhang S., Broadhurst R., L'Huillier P., Cooper G.J.,

Diabetes 59:161-171(2010)

Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxicity.

Bedrood S., Jayasinghe S., Sieburth D., Chen M., Erbel S., Butler P.C., Langen R., Ritzel R.A.,

Biochemistry 48:10568-10576(2009)

Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro.

Khemtemourian L., Lahoz Casarramona G., Suylen D.P., Hackeng T.M., Meeldijk J.D., de Kruijff B., Hoppener J.W., Killian J.A.,

Biochemistry 48:10918-10925(2009)

Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.

Guo Q., Manolopoulou M., Bian Y., Schilling A.B., Tang W.J.,

J Mol Biol 395:430-443(2010)

Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.

BRIGHT Consortium, Talmud P.J., Drenos F., Shah S., Shah T., Palmen J., Verzilli C., Gaunt T.R., Pallas J., Lovering R., Li K., Casas J.P., Sofat R., Kumari M., Rodriguez S., Johnson T., Newhouse S.J., Dominiczak A., Samani N.J., Kjeldsen S.,

Am J Hum Genet 85:628-642(2009)

Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa.

Wojcik M.H., Meenaghan E., Lawson E.A., Misra M., Klibanski A., Miller K.K.,

Bone 46:796-800(2010)

Evidence for a partially structured state of the amylin monomer.

Vaiana S.M., Best R.B., Yau W.M., Eaton W.A., Hofrichter J.,

Biophys J 97:2948-2957(2009)

The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors.

Cao P., Meng F., Abedini A., Raleigh D.P.,

Biochemistry 49:872-881(2010)

Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction.

Lim Y.A., Rhein V., Baysang G., Meier F., Poljak A., Raftery M.J., Guilhaus M., Ittner L.M., Eckert A., Gotz J.,

Proteomics 10:1621-1633(2010)

Identification of type 2 diabetes-associated combination of SNPs using support vector machine.

Ban H.J., Heo J.Y., Oh K.S., Park K.J.,

BMC Genet 11:26-26(2010)

Pathologic changes and glucose homeostasis according to expression of human islet amyloid polypeptide in type 2 diabetic patients.

Park J.Y., No H.S., Ahn Y.R., Oh S.H., Kim Y.S., Kim S.Y., Jang K.T., Kim S.W., Chung J.H., Min Y.K., Heo J.S., Choi S.H., Choi D.W., Lee M.S., Lee M.K., Kim J.H., Kim K.W.,

J Histochem Cytochem 58:731-740(2010)

Effect of the disulfide bond on the monomeric structure of human amylin studied by combined Hamiltonian and temperature replica exchange molecular dynamics simulations.

Laghaei R., Mousseau N., Wei G.,

J Phys Chem B 114:7071-7077(2010)

Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus.

Zheng X., Ren W., Zhang S., Liu J., Li S., Li J., Yang P., He J., Su S., Li P.,

Acta Diabetol 47:265-270(2010)

Role of zinc in human islet amyloid polypeptide aggregation.

Brender J.R., Hartman K., Nanga R.P., Popovych N., de la Salud Bea R., Vivekanandan S., Marsh E.N., Ramamoorthy A.,

J Am Chem Soc 132:8973-8983(2010)

Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro.

Exley C., House E., Patel T., Wu L., Fraser P.E.,

J Inorg Biochem 104:1125-1129(2010)

Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

Bailey S.D., Xie C., Do R., Montpetit A., Diaz R., Mohan V., Keavney B., Yusuf S., Gerstein H.C., Engert J.C., Anand S.,

Diabetes Care 33:2250-2253(2010)

Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: a combined fluorescence and IR study of p-cyanophenylalanine analogs of islet amyloid polypeptide.

Marek P., Mukherjee S., Zanni M.T., Raleigh D.P.,

J Mol Biol 400:878-888(2010)

The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of beta-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.

Chien V., Aitken J.F., Zhang S., Buchanan C.M., Hickey A., Brittain T., Cooper G.J., Loomes K.M.,

Biochem J 432:113-121(2010)

Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.

Shenhar-Tsarfaty S., Bruck T., Bennett E.R., Bravman T., Aassayag E.B., Waiskopf N., Rogowski O., Bornstein N., Berliner S., Soreq H.,

J Cell Mol Med 15:1747-1756(2011)

Heparan sulfate proteoglycans in amyloidosis.

Zhang X., Li J.P.,

Prog Mol Biol Transl Sci 93:309-334(2010)

The role of aromatic side-chains in amyloid growth and membrane interaction of the islet amyloid polypeptide fragment LANFLVH.

Milardi D., Sciacca M.F., Pappalardo M., Grasso D.M., La Rosa C.,

Eur Biophys J 40:1-12(2011)

The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.

Sabate R., Espargaro A., de Groot N.S., Valle-Delgado J.J., Fernandez-Busquets X., Ventura S.,

J Mol Biol 404:337-352(2010)

Stable and metastable states of human amylin in solution.

Reddy A.S., Wang L., Singh S., Ling Y.L., Buchanan L., Zanni M.T., Skinner J.L., de Pablo J.J.,

Biophys J 99:2208-2216(2010)

Porcine islet amyloid polypeptide fragments are refractory to amyloid formation.

Zhang X., Cheng B., Gong H., Li C., Chen H., Zheng L., Huang K.,

FEBS Lett 585:71-77(2011)

Positive inotropic, positive chronotropic and coronary vasodilatory effects of rat amylin: mechanisms of amylin-induced positive inotropy.

Kaygisiz Z., Ozden H., Erkasap N., Koken T., Gunduz T., Ikizler M., Kural T.,

Acta Physiol Hung 97:362-374(2010)

The molecular basis of distinct aggregation pathways of islet amyloid polypeptide.

Wei L., Jiang P., Xu W., Li H., Zhang H., Yan L., Chan-Park M.B., Liu X.W., Tang K., Mu Y., Pervushin K.,

J Biol Chem 286:6291-6300(2011)

Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions.

Zhao J., Yu X., Liang G., Zheng J.,

Biomacromolecules 12:210-220(2011)

Immunoglobulin heavy-chain-associated amyloidosis.

Eulitz M., Weiss D.T., Solomon A.,

Proc Natl Acad Sci U S A 87:6542-6546(1990)

Islet amyloid polypeptide gene variation (IAPP) and the risk of incident type 2 diabetes mellitus: the Women's Genome Health Study.

Zee R.Y., Pulido-Perez P., Perez-Fuentes R., Ridker P.M., Chasman D.I., Romero J.R.,

Clin Chim Acta 412:785-787(2011)

Comparing the structural properties of human and rat islet amyloid polypeptide by MD computer simulations.

Andrews M.N., Winter R.,

Biophys Chem 156:43-50(2011)

Amylin and selective glucoregulatory peptide alterations during prolonged exercise.

Kraemer R.R., Francois M.R., Sehgal K., Sirikul B., Valverde R.A., Castracane V.D.,

Med Sci Sports Exerc 43:1451-1456(2011)

Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

Brender J.R., Lee E.L., Hartman K., Wong P.T., Ramamoorthy A., Steel D.G., Gafni A.,

Biophys J 100:685-692(2011)

Heterogeneous amylin fibril growth mechanisms imaged by total internal reflection fluorescence microscopy.

Patil S.M., Mehta A., Jha S., Alexandrescu A.T.,

Biochemistry 50:2808-2819(2011)

Mechanism of amylin fibrillization enhancement by heparin.

Jha S., Patil S.M., Gibson J., Nelson C.E., Alder N.N., Alexandrescu A.T.,

J Biol Chem 286:22894-22904(2011)

Hexafluoroisopropanol induces amyloid fibrils of islet amyloid polypeptide by enhancing both hydrophobic and electrostatic interactions.

Yanagi K., Ashizaki M., Yagi H., Sakurai K., Lee Y.H., Goto Y.,

J Biol Chem 286:23959-23966(2011)

Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity.

Last N.B., Rhoades E., Miranker A.D.,

Proc Natl Acad Sci U S A 108:9460-9465(2011)

A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc.

Salamekh S., Brender J.R., Hyung S.J., Nanga R.P., Vivekanandan S., Ruotolo B.T., Ramamoorthy A.,

J Mol Biol 410:294-306(2011)

Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.

Tomita T.,

Islets 3:166-174(2011)

Drosophila melanogaster as a model system for studies of islet amyloid polypeptide aggregation.

Schultz S.W., Nilsson K.P., Westermark G.T.,

PLoS One 6:e20221-e20221(2011)

Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment.

Nanga R.P., Brender J.R., Vivekanandan S., Ramamoorthy A.,

Biochim Biophys Acta 1808:2337-2342(2011)

Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Westermark P., Andersson A., Westermark G.T.,

Physiol Rev 91:795-826(2011)

Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.

Trikha S., Jeremic A.M.,

J Biol Chem 286:36086-36097(2011)

2DIR spectroscopy of human amylin fibrils reflects stable beta-sheet structure.

Wang L., Middleton C.T., Singh S., Reddy A.S., Woys A.M., Strasfeld D.B., Marek P., Raleigh D.P., de Pablo J.J., Zanni M.T., Skinner J.L.,

J Am Chem Soc 133:16062-16071(2011)

Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese.

Hou X., Sun L., Li Z., Mou H., Yu Z., Li H., Jiang P., Yu D., Wu H., Ye X., Lin X., Le Y.,

PLoS One 6:e24815-e24815(2011)

beta-Amyloid protein (Abeta) and human amylin regulation of apoptotic genes occurs through the amylin receptor.

Jhamandas J.H., Mactavish D.,

Apoptosis 17:37-47(2012)

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.

Westermark P., Engstrom U., Johnson K.H., Westermark G.T., Betsholtz C.,

Proc Natl Acad Sci U S A 87:5036-5040(1990)

Co-assembly of human islet amyloid polypeptide (hIAPP)/insulin.

Liu P., Zhang S., Chen M.S., Liu Q., Wang C., Wang C., Li Y.M., Besenbacher F., Dong M.,

Chem Commun (Camb) 48:191-193(2012)

cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.

Subramanian S.L., Hull R.L., Zraika S., Aston-Mourney K., Udayasankar J., Kahn S.E.,

Diabetologia 55:166-174(2012)

Beta structure motifs of islet amyloid polypeptides identified through surface-mediated assemblies.

Mao X.B., Wang C.X., Wu X.K., Ma X.J., Liu L., Zhang L., Niu L., Guo Y.Y., Li D.H., Yang Y.L., Wang C.,

Proc Natl Acad Sci U S A 108:19605-19610(2011)

Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling.

Bailey J., Potter K.J., Verchere C.B., Edelstein-Keshet L., Coombs D.,

Phys Biol 8:066009-066009(2011)

Cross-amyloid interaction of Abeta and IAPP at lipid membranes.

Seeliger J., Evers F., Jeworrek C., Kapoor S., Weise K., Andreetto E., Tolan M., Kapurniotu A., Winter R.,

Angew Chem Int Ed Engl 51:679-683(2012)

Fibril structure of human islet amyloid polypeptide.

Bedrood S., Li Y., Isas J.M., Hegde B.G., Baxa U., Haworth I.S., Langen R.,

J Biol Chem 287:5235-5241(2012)

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

Westermark G.T., Davalli A.M., Secchi A., Folli F., Kin T., Toso C., Shapiro A.M., Korsgren O., Tufveson G., Andersson A., Westermark P.,

Transplantation 93:219-223(2012)

Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20.

Cao P., Tu L.H., Abedini A., Levsh O., Akter R., Patsalo V., Schmidt A.M., Raleigh D.P.,

J Mol Biol 421:282-295(2012)

Amphiphilic adsorption of human islet amyloid polypeptide aggregates to lipid/aqueous interfaces.

Xiao D., Fu L., Liu J., Batista V.S., Yan E.C.,

J Mol Biol 421:537-547(2012)

Effect of sequence variation on the mechanical response of amyloid fibrils probed by steered molecular dynamics simulation.

Ndlovu H., Ashcroft A.E., Radford S.E., Harris S.A.,

Biophys J 102:587-596(2012)

Islet amyloid polypeptide triggers limited complement activation and binds complement inhibitor C4b-binding protein, which enhances fibril formation.

Sjolander J., Westermark G.T., Renstrom E., Blom A.M.,

J Biol Chem 287:10824-10833(2012)

How type II diabetes-related islet amyloid polypeptide damages lipid bilayers.

Lee C.C., Sun Y., Huang H.W.,

Biophys J 102:1059-1068(2012)

Nucleobindin 1 caps human islet amyloid polypeptide protofibrils to prevent amyloid fibril formation.

Gupta R., Kapoor N., Raleigh D.P., Sakmar T.P.,

J Mol Biol 421:378-389(2012)

Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations.

Zhang Y., Luo Y., Deng Y., Mu Y., Wei G.,

PLoS One 7:e38191-e38191(2012)

Deamidation accelerates amyloid formation and alters amylin fiber structure.

Dunkelberger E.B., Buchanan L.E., Marek P., Cao P., Raleigh D.P., Zanni M.T.,

J Am Chem Soc 134:12658-12667(2012)

The occurrence of islet amyloid polypeptide amyloidosis in Japanese subjects.

Su Y., Misumi Y., Ueda M., Shono M., Tasaki M., Guo J., Jono H., Obayashi K., Senokuchi T., Yamagata K., Ando Y.,

Pancreas 41:971-973(2012)

Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.

Sasahara K., Morigaki K., Okazaki T., Hamada D.,

Biochemistry 51:6908-6919(2012)

Antimicrobial activity of human islet amyloid polypeptides: an insight into amyloid peptides' connection with antimicrobial peptides.

Wang L., Liu Q., Chen J.C., Cui Y.X., Zhou B., Chen Y.X., Zhao Y.F., Li Y.M.,

Biol Chem 393:641-646(2012)

Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects.

Marek P.J., Patsalo V., Green D.F., Raleigh D.P.,

Biochemistry 51:8478-8490(2012)

Molecular dynamics simulation study on the molecular structures of the amylin fibril models.

Xu W., Su H., Zhang J.Z., Mu Y.,

J Phys Chem B 116:13991-13999(2012)

Islet amyloid polypeptide: aggregation and fibrillogenesis in vitro and its inhibition.

Seeliger J., Winter R.,

Subcell Biochem 65:185-209(2012)

Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.

Aston-Mourney K., Zraika S., Udayasankar J., Subramanian S.L., Green P.S., Kahn S.E., Hull R.L.,

J Biol Chem 288:3553-3559(2013)

Evidence of π-stacking interactions in the self-assembly of hIAPP(22-29).

Profit A.A., Felsen V., Chinwong J., Mojica E.R., Desamero R.Z.,

Proteins 81:690-703(2013)

Role of aromatic interactions in amyloid formation by islet amyloid polypeptide.

Tu L.H., Raleigh D.P.,

Biochemistry 52:333-342(2013)

Rosiglitazone treatment does not decrease amyloid deposition in transplanted islets from transgenic mice expressing human islet amyloid polypeptide.

Udayasankar J., Zraika S., Aston-Mourney K., Subramanian S.L., Brooks-Worrell B.M., Taborsky G.J., Hull R.L.,

Transplant Proc 45:574-579(2013)

Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP.

Sciacca M.F., Milardi D., Messina G.M., Marletta G., Brender J.R., Ramamoorthy A., La Rosa C.,

Biophys J 104:173-184(2013)

Mechanisms of islet amyloidosis toxicity in type 2 diabetes.

Abedini A., Schmidt A.M.,

FEBS Lett 587:1119-1127(2013)

Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Cao P., Marek P., Noor H., Patsalo V., Tu L.H., Wang H., Abedini A., Raleigh D.P.,

FEBS Lett 587:1106-1118(2013)

Amide proton solvent protection in amylin fibrils probed by quenched hydrogen exchange NMR.

Alexandrescu A.T.,

PLoS One 8:e56467-e56467(2013)

A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence.

Nath A., Rhoades E.,

FEBS Lett 587:1096-1105(2013)

Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20-29) fragments.

Brender J.R., Heyl D.L., Samisetti S., Kotler S.A., Osborne J.M., Pesaru R.R., Ramamoorthy A.,

Phys Chem Chem Phys 15:8908-8915(2013)

Cosolvent effects on the fibrillation reaction of human IAPP.

Seeliger J., Estel K., Erwin N., Winter R.,

Phys Chem Chem Phys 15:8902-8907(2013)

Heme bound amylin: spectroscopic characterization, reactivity, and relevance to type 2 diabetes.

Mukherjee S., Dey S.G.,

Inorg Chem 52:5226-5235(2013)

alpha-helix to beta-hairpin transition of human amylin monomer.

Singh S., Chiu C.C., Reddy A.S., de Pablo J.J.,

J Chem Phys 138:155101-155101(2013)

Thermodynamic and structural determinants of differential Pdx1 binding to elements from the insulin and IAPP promoters.

Bastidas M., Showalter S.A.,

J Mol Biol 425:3360-3377(2013)

Structural similarities and differences between amyloidogenic and non-amyloidogenic islet amyloid polypeptide (IAPP) sequences and implications for the dual physiological and pathological activities of these peptides.

Wu C., Shea J.E.,

PLoS Comput Biol 9:e1003211-e1003211(2013)

Effect of proline mutations on the monomer conformations of amylin.

Chiu C.C., Singh S., de Pablo J.J.,

Biophys J 105:1227-1235(2013)

Full length amylin oligomer aggregation: insights from molecular dynamics simulations and implications for design of aggregation inhibitors.

Berhanu W.M., Masunov A.E.,

J Biomol Struct Dyn 32:1651-1669(2014)

Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.

Snow A.D., Kisilevsky R.,

Lab Invest 53:37-44(1985)

Membrane permeation induced by aggregates of human islet amyloid polypeptides.

Poojari C., Xiao D., Batista V.S., Strodel B.,

Biophys J 105:2323-2332(2013)

Insulin, islet amyloid polypeptide and C-peptide interactions evaluated by mass spectrometric analysis.

Landreh M., Alvelius G., Johansson J., Jornvall H.,

Rapid Commun Mass Spectrom 28:178-184(2014)

Non-selective ion channel activity of polymorphic human islet amyloid polypeptide (amylin) double channels.

Zhao J., Hu R., Sciacca M.F., Brender J.R., Chen H., Ramamoorthy A., Zheng J.,

Phys Chem Chem Phys 16:2368-2377(2014)

Endogenous amylin and glucagon-like peptide-1 concentrations are not associated with gastric emptying in critical illness.

Summers M.J., DI Bartolomeo A.E., Zaknic A.V., Chapman M.J., Nguyen N.Q., Zacharakis B., Rayner C.K., Horowitz M., Deane A.M.,

Acta Anaesthesiol Scand 58:235-242(2014)

Association between amylin and amyloid-beta peptides in plasma in the context of apolipoprotein E4 allele.

Qiu W.Q., Wallack M., Dean M., Liebson E., Mwamburi M., Zhu H.,

PLoS One 9:e88063-e88063(2014)

Role of sequence and structural polymorphism on the mechanical properties of amyloid fibrils.

Yoon G., Lee M., Kim J.I., Na S., Eom K.,

PLoS One 9:e88502-e88502(2014)

High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus.

Paulsson J.F., Ludvigsson J., Carlsson A., Casas R., Forsander G., Ivarsson S.A., Kockum I., Lernmark A., Marcus C., Lindblad B., Westermark G.T.,

PLoS One 9:e93053-e93053(2014)

Mutational analysis of preamyloid intermediates: the role of his-tyr interactions in islet amyloid formation.

Tu L.H., Serrano A.L., Zanni M.T., Raleigh D.P.,

Biophys J 106:1520-1527(2014)

Exploring the influence of EGCG on the beta-sheet-rich oligomers of human islet amyloid polypeptide (hIAPP1-37) and identifying its possible binding sites from molecular dynamics simulation.

Wang Q., Guo J., Jiao P., Liu H., Yao X.,

PLoS One 9:e94796-e94796(2014)

The study of regulatory effects of Pdx-1, MafA and NeuroD1 on the activity of porcine insulin promoter and the expression of human islet amyloid polypeptide.

Liu X.D., Ruan J.X., Xia J.H., Yang S.L., Fan J.H., Li K.,

Mol Cell Biochem 394:59-66(2014)

Amylin in vasodilation, energy expenditure and inflammation.

Yang F.,

Front Biosci (Landmark Ed) 19:936-944(2014)

Positive association between plasma amylin and cognition in a homebound elderly population.

Qiu W.Q., Au R., Zhu H., Wallack M., Liebson E., Li H., Rosenzweig J., Mwamburi M., Stern R.A.,

J Alzheimers Dis 42:555-563(2014)

Engineered aggregation inhibitor fusion for production of highly amyloidogenic human islet amyloid polypeptide.

Mirecka E.A., Gremer L., Schiefer S., Oesterhelt F., Stoldt M., Willbold D., Hoyer W.,

J Biotechnol 191:221-227(2014)

Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression.

Cadavez L., Montane J., Alcarraz-Vizan G., Visa M., Vidal-Fabrega L., Servitja J.M., Novials A.,

PLoS One 9:e101797-e101797(2014)

Amyloidogenic peptide oligomer accumulation in autophagy-deficient beta cells induces diabetes.

Kim J., Cheon H., Jeong Y.T., Quan W., Kim K.H., Cho J.M., Lim Y.M., Oh S.H., Jin S.M., Kim J.H., Lee M.K., Kim S., Komatsu M., Kang S.W., Lee M.S.,

J Clin Invest 124:3311-3324(2014)

Human IAPP-induced pancreatic beta cell toxicity and its regulation by autophagy.

Shigihara N., Fukunaka A., Hara A., Komiya K., Honda A., Uchida T., Abe H., Toyofuku Y., Tamaki M., Ogihara T., Miyatsuka T., Hiddinga H.J., Sakagashira S., Koike M., Uchiyama Y., Yoshimori T., Eberhardt N.L., Fujitani Y., Watada H.,

J Clin Invest 124:3634-3644(2014)

Autophagy defends pancreatic beta cells from human islet amyloid polypeptide-induced toxicity.

Rivera J.F., Costes S., Gurlo T., Glabe C.G., Butler P.C.,

J Clin Invest 124:3489-3500(2014)

The role of copper(II) in the aggregation of human amylin.

Sinopoli A., Magri A., Milardi D., Pappalardo M., Pucci P., Flagiello A., Titman J.J., Nicoletti V.G., Caruso G., Pappalardo G., Grasso G.,

Metallomics 6:1841-1852(2014)

Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model.

Despa S., Sharma S., Harris T.R., Dong H., Li N., Chiamvimonvat N., Taegtmeyer H., Margulies K.B., Hammock B.D., Despa F.,

J Am Heart Assoc 3:0-0(2014)

Human IAPP amyloidogenic properties and pancreatic beta-cell death.

Fernandez M.S.,

Cell Calcium 56:416-427(2014)

Inhibition of BACE2 counteracts hIAPP-induced insulin secretory defects in pancreatic beta-cells.

Alcarraz-Vizan G., Casini P., Cadavez L., Visa M., Montane J., Servitja J.M., Novials A.,

FASEB J 29:95-104(2015)

IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.

Venkatanarayan A., Raulji P., Norton W., Chakravarti D., Coarfa C., Su X., Sandur S.K., Ramirez M.S., Lee J., Kingsley C.V., Sananikone E.F., Rajapakshe K., Naff K., Parker-Thornburg J., Bankson J.A., Tsai K.Y., Gunaratne P.H., Flores E.R.,

Nature 517:626-630(2015)

Free energy simulations of amylin I26P mutation in a lipid bilayer.

Jalili S., Maleki A., Akhavan M., Najafi B., Schofield J.,

Eur Biophys J 44:37-47(2015)

Dewetting transition assisted clearance of (NFGAILS) amyloid fibrils from cell membranes by graphene.

Liu J., Yang Z., Li H., Gu Z., Garate J.A., Zhou R.,

J Chem Phys 141:22D520-22D520(2014)

Cholesterol modulates the interaction of the islet amyloid polypeptide with membranes.

Caillon L., Duma L., Lequin O., Khemtemourian L.,

Mol Membr Biol 31:239-249(2014)

Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells.

Mitsuhashi M., Mitsuhashi T., Payan D.G.,

J Biol Chem 264:18356-18362(1989)

Serum Preptin and Amylin Values in Psoriasis Vulgaris and Behcet's Patients.

Dogan F.B., Cicek D., Aydin S., Dertlioglu S.B., Halisdemir N., Ucak H., Demir B., Erden I.,

J Clin Lab Anal 30:165-168(2016)

Inhibition of IAPP aggregation by insulin depends on the insulin oligomeric state regulated by zinc ion concentration.

Nedumpully-Govindan P., Ding F.,

Sci Rep 5:8240-8240(2015)

Interfacial interaction and lateral association of cross-seeding assemblies between hIAPP and rIAPP oligomers.

Zhang M., Hu R., Chen H., Chang Y., Gong X., Liu F., Zheng J.,

Phys Chem Chem Phys 17:10373-10382(2015)

Computational re-engineering of Amylin sequence with reduced amyloidogenic potential.

Smaoui M.R., Waldispuhl J.,

BMC Struct Biol 15:7-7(2015)

Structural studies and cytotoxicity assays of "aggregation-prone" IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin.

Louros N.N., Tsiolaki P.L., Zompra A.A., Pappa E.V., Magafa V., Pairas G., Cordopatis P., Cheimonidou C., Trougakos I.P., Iconomidou V.A., Hamodrakas S.J.,

Biopolymers 104:196-205(2015)

Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis.

Oskarsson M.E., Singh K., Wang J., Vlodavsky I., Li J.P., Westermark G.T.,

J Biol Chem 290:15121-15132(2015)

Nanoscale Heterogeneity of the Molecular Structure of Individual hIAPP Amyloid Fibrils Revealed with Tip-Enhanced Raman Spectroscopy.

vandenAkker C.C., Deckert-Gaudig T., Schleeger M., Velikov K.P., Deckert V., Bonn M., Koenderink G.H.,

Small 11:4131-4139(2015)

Polymorphic Associations and Structures of the Cross-Seeding of Abeta1-42 and hIAPP1-37 Polypeptides.

Zhang M., Hu R., Chen H., Gong X., Zhou F., Zhang L., Zheng J.,

J Chem Inf Model 55:1628-1639(2015)

Secondary Structure of Rat and Human Amylin across Force Fields.

Hoffmann K.Q., McGovern M., Chiu C.C., de Pablo J.J.,

PLoS One 10:e0134091-e0134091(2015)

Characterization of Parallel beta-Sheets at Interfaces by Chiral Sum Frequency Generation Spectroscopy.

Fu L., Wang Z., Psciuk B.T., Xiao D., Batista V.S., Yan E.C.,

J Phys Chem Lett 6:1310-1315(2015)

Slow Internal Dynamics and Charge Expansion in the Disordered Protein CGRP: A Comparison with Amylin.

Sizemore S.M., Cope S.M., Roy A., Ghirlanda G., Vaiana S.M.,

Biophys J 109:1038-1048(2015)

Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.

Li H., Ha E., Donaldson R.P., Jeremic A.M., Vertes A.,

Anal Chem 87:9829-9837(2015)

Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity.

Meier D.T., Tu L.H., Zraika S., Hogan M.F., Templin A.T., Hull R.L., Raleigh D.P., Kahn S.E.,

J Biol Chem 290:30475-30485(2015)

Promotion or Inhibition of Islet Amyloid Polypeptide Aggregation by Zinc Coordination Depends on Its Relative Concentration.

Nedumpully-Govindan P., Yang Y., Andorfer R., Cao W., Ding F.,

Biochemistry 54:7335-7344(2015)

Protein disulfide isomerase ameliorates beta-cell dysfunction in pancreatic islets overexpressing human islet amyloid polypeptide.

Montane J., de Pablo S., Obach M., Cadavez L., Castano C., Alcarraz-Vizan G., Visa M., Rodriguez-Comas J., Parrizas M., Servitja J.M., Novials A.,

Mol Cell Endocrinol 420:57-65(2016)

How the imidazole ring modulates amyloid formation of islet amyloid polypeptide: A chemical modification study.

Zhang X., Liu J., Huang L., Yang X., Petersen R.B., Sun Y., Gong H., Zheng L., Huang K.,

Biochim Biophys Acta 1860:719-726(2016)

Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates.

Westwell-Roper C., Denroche H.C., Ehses J.A., Verchere C.B.,

J Biol Chem 291:8908-8917(2016)

Conformational Dynamics of the Human Islet Amyloid Polypeptide in a Membrane Environment: Toward the Aggregation Prone Form.

Skeby K.K., Andersen O.J., Pogorelov T.V., Tajkhorshid E., Schiott B.,

Biochemistry 55:2031-2042(2016)

Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment.

Rosas P.C., Nagaraja G.M., Kaur P., Panossian A., Wickman G., Garcia L.R., Al-Khamis F.A., Asea A.A.,

PLoS One 11:e0149409-e0149409(2016)

The effects of chondroitin sulfate and serum albumin on the fibrillation of human islet amyloid polypeptide at phospholipid membranes.

Li Y., Wang L., Lu T., Wei Y., Li F.,

Phys Chem Chem Phys 18:12000-12008(2016)

Peptide Inhibitors of the amyloidogenesis of IAPP: verification of the hairpin-binding geometry hypothesis.

Sivanesam K., Shu I., Huggins K.N., Tatarek-Nossol M., Kapurniotu A., Andersen N.H.,

FEBS Lett 590:2575-2583(2016)

The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo.

Jiang Y., Meng Q., Chen B., Shen H., Yan B., Sun B.,

Biochem Biophys Res Commun 478:293-299(2016)

The Role of Cholesterol in Driving IAPP-Membrane Interactions.

Sciacca M.F., Lolicato F., Di Mauro G., Milardi D., D'Urso L., Satriano C., Ramamoorthy A., La Rosa C.,

Biophys J 111:140-151(2016)

The dye SYPRO orange binds to amylin amyloid fibrils but not pre-fibrillar intermediates.

Wong A.G., Raleigh D.P.,

Protein Sci 25:1834-1840(2016)

C4b-binding Protein Protects beta-Cells from Islet Amyloid Polypeptide-induced Cytotoxicity.

Sjolander J., Byman E., Kulak K., Nilsson S.C., Zhang E., Krus U., Westermark G.T., Storm P., King B.C., Renstrom E., Blom A.M.,

J Biol Chem 291:21644-21655(2016)

Structural Characterization of Fibrils from Recombinant Human Islet Amyloid Polypeptide by Solid-State NMR: The Central FGAILS Segment Is Part of the beta-Sheet Core.

Weirich F., Gremer L., Mirecka E.A., Schiefer S., Hoyer W., Heise H.,

PLoS One 11:e0161243-e0161243(2016)

beta-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor.

Mirecka E.A., Feuerstein S., Gremer L., Schroder G.F., Stoldt M., Willbold D., Hoyer W.,

Sci Rep 6:33474-33474(2016)

Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions.

Caruso G., Distefano D.A., Parlascino P., Fresta C.G., Lazzarino G., Lunte S.M., Nicoletti V.G.,

Mol Cell Biochem 425:85-93(2017)

Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.

Costa P.P., Figueira A.S., Bravo F.R.,

Proc Natl Acad Sci U S A 75:4499-4503(1978)

Atomic structures of fibrillar segments of hIAPP suggest tightly mated beta-sheets are important for cytotoxicity.

Krotee P., Rodriguez J.A., Sawaya M.R., Cascio D., Reyes F.E., Shi D., Hattne J., Nannenga B.L., Oskarsson M.E., Philipp S., Griner S., Jiang L., Glabe C.G., Westermark G.T., Gonen T., Eisenberg D.S.,

Elife 6:0-0(2017)

Dual role of interleukin-1beta in islet amyloid formation and its beta-cell toxicity: Implications for type 2 diabetes and islet transplantation.

Park Y.J., Warnock G.L., Ao Z., Safikhan N., Meloche M., Asadi A., Kieffer T.J., Marzban L.,

Diabetes Obes Metab 19:682-694(2017)

Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide.

Xu Z.X., Zhang Q., Ma G.L., Chen C.H., He Y.M., Xu L.H., Zhang Y., Zhou G.R., Li Z.H., Yang H.J., Zhou P.,

J Diabetes Res 2016:1867059-1867059(2016)

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes.

Rodriguez Camargo D.C., Tripsianes K., Buday K., Franko A., Gobl C., Hartlmuller C., Sarkar R., Aichler M., Mettenleiter G., Schulz M., Boddrich A., Erck C., Martens H., Walch A.K., Madl T., Wanker E.E., Conrad M., de Angelis M.H., Reif B.,

Sci Rep 7:44041-44041(2017)

BACE2 suppression promotes beta-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.

Alcarraz-Vizan G., Castano C., Visa M., Montane J., Servitja J.M., Novials A.,

Cell Mol Life Sci 74:2827-2838(2017)

The effect of aluminum ion on the aggregation of human islet amyloid polypeptide (11-28).

Su L., Lu C., Yan P., Zhang N., Cai S., Zhang G., Zhou X., Bin Li,

Acta Biochim Biophys Sin (Shanghai) 49:355-360(2017)

Down-regulation of islet amyloid polypeptide expression induces death of human annulus fibrosus cells via mitochondrial and death receptor pathways.

Wu X., Wang K., Hua W., Li S., Liu X., Liu W., Song Y., Zhang Y., Shao Z., Yang C.,

Biochim Biophys Acta Mol Basis Dis 1863:1479-1491(2017)

Membrane Interactions of hIAPP Monomer and Oligomer with Lipid Membranes by Molecular Dynamics Simulations.

Zhang M., Ren B., Liu Y., Liang G., Sun Y., Xu L., Zheng J.,

ACS Chem Neurosci 8:1789-1800(2017)

Tracking the amyloidogenic core of IAPP amyloid fibrils: Insights from micro-Raman spectroscopy.

Louros N.N., Tsiolaki P.L., Baltoumas F.A., Chryssikos G.D., Gionis V., Hamodrakas S.J., Iconomidou V.A.,

J Struct Biol 199:140-152(2017)

N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Lee S.M., Booe J.M., Gingell J.J., Sjoelund V., Hay D.L., Pioszak A.A.,

Biochemistry 56:3380-3393(2017)

Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly.

Bakou M., Hille K., Kracklauer M., Spanopoulou A., Frost C.V., Malideli E., Yan L.M., Caporale A., Zacharias M., Kapurniotu A.,

J Biol Chem 292:14587-14602(2017)

Insight into a New Binding Site of Zinc Ions in Fibrillar Amylin.

Wineman-Fisher V., Miller Y.,

ACS Chem Neurosci 8:2078-2087(2017)

Sequence-Dependent Self-Assembly and Structural Diversity of Islet Amyloid Polypeptide-Derived beta-Sheet Fibrils.

Wang S.T., Lin Y., Spencer R.K., Thomas M.R., Nguyen A.I., Amdursky N., Pashuck E.T., Skaalure S.C., Song C.Y., Parmar P.A., Morgan R.M., Ercius P., Aloni S., Zuckermann R.N., Stevens M.M.,

ACS Nano 11:8579-8589(2017)

Structural Properties of Human IAPP Dimer in Membrane Environment Studied by All-Atom Molecular Dynamics Simulations.

Liu N., Duan M., Yang M.,

Sci Rep 7:7915-7915(2017)

Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes.

Zhang X.X., Qiao Y.C., Li W., Zou X., Chen Y.L., Shen J., Liao Q.Y., Zhang Q.J., He L., Zhao H.L.,

Immunol Res 66:179-186(2018)

Mutation in cystatin C gene causes hereditary brain haemorrhage.

Palsdottir A., Abrahamson M., Thorsteinsson L., Arnason A., Olafsson I., Grubb A., Jensson O.,

Lancet 2:603-604(1988)

Recombinant human islet amyloid polypeptide forms shorter fibrils and mediates beta-cell apoptosis via generation of oxidative stress.

Dubey R., Minj P., Malik N., Sardesai D.M., Kulkarni S.H., Acharya J.D., Bhavesh N.S., Sharma S., Kumar A.,

Biochem J 474:3915-3934(2017)

Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate.

Rodriguez Camargo D.C., Korshavn K.J., Jussupow A., Raltchev K., Goricanec D., Fleisch M., Sarkar R., Xue K., Aichler M., Mettenleiter G., Walch A.K., Camilloni C., Hagn F., Reif B., Ramamoorthy A.,

Elife 6:0-0(2017)

Amylin in the insulin resistance of patients with rheumatoid arthritis.

Ferraz-Amaro I., Lopez-Mejias R., Tejera-Segura B., de Vera-Gonzalez A.M., Ubilla B., Olmos J.M., Hernandez J.L., Gonzalez-Gay M.A.,

Clin Exp Rheumatol 36:421-427(2018)

Kinetic and Conformational Insights into Islet Amyloid Polypeptide Self-Assembly Using a Biarsenical Fluorogenic Probe.

Quittot N., Sebastiao M., Al-Halifa S., Bourgault S.,

Bioconjug Chem 29:517-527(2018)

BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.

Oskarsson M.E., Hermansson E., Wang Y., Welsh N., Presto J., Johansson J., Westermark G.T.,

Proc Natl Acad Sci U S A 115:E2752-E2761(2018)

Protein aggregates and proteostasis in aging: Amylin and beta-cell function.

Press M., Jung T., Konig J., Grune T., Hohn A.,

Mech Ageing Dev 177:46-54(2019)

Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes.

Stewart B.D., Scott C.E., McCoy T.P., Yin G., Despa F., Despa S., Kekenes-Huskey P.M.,

Cell Calcium 71:65-74(2018)

Pancreatic beta cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics.

Hernandez M.G., Aguilar A.G., Burillo J., Oca R.G., Manca M.A., Novials A., Alcarraz-Vizan G., Guillen C., Benito M.,

Cell Death Dis 9:481-481(2018)

Schiff base oxovanadium complexes resist the assembly behavior of human islet amyloid polypeptide.

Xu J., Gong G., Huang X., Du W.,

J Inorg Biochem 186:60-69(2018)

Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels.

Schultz N., Byman E., Wennstrom M.,

Neurobiol Aging 69:94-101(2018)

Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic beta-cells.

Chatterjee Bhowmick D., Jeremic A.,

J Biol Chem 293:14210-14223(2018)

IAPP/amylin deposition, which is correlated with expressions of ASC and IL-1beta in beta-cells of Langerhans' islets, directly initiates NLRP3 inflammasome activation.

Morikawa S., Kaneko N., Okumura C., Taguchi H., Kurata M., Yamamoto T., Osawa H., Nakanishi A., Zako T., Masumoto J.,

Int J Immunopathol Pharmacol 32:2058738418788749-2058738418788749(2018)

Electrostatic Polarization Effect on Cooperative Aggregation of Full Length Human Islet Amyloid.

Li Y., Wang X., Ren L., Cao X., Ji C., Xia F., Zhang J.Z.H.,

J Chem Inf Model 58:1587-1595(2018)

Sub-Toxic Human Amylin Fragment Concentrations Promote the Survival and Proliferation of SH-SY5Y Cells via the Release of VEGF and HspB5 from Endothelial RBE4 Cells.

Caruso G., Fresta C.G., Lazzarino G., Distefano D.A., Parlascino P., Lunte S.M., Lazzarino G., Caraci F.,

Int J Mol Sci 19:0-0(2018)

Zinc boosts EGCG's hIAPP amyloid Inhibition both in solution and membrane.

Lee Y.H., Lin Y., Cox S.J., Kinoshita M., Sahoo B.R., Ivanova M., Ramamoorthy A.,

Biochim Biophys Acta Proteins Proteom 1867:529-536(2019)

Does deamidation of islet amyloid polypeptide accelerate amyloid fibril formation?

Lam Y.P.Y., Wootton C.A., Hands-Portman I., Wei J., Chiu C.K.C., Romero-Canelon I., Lermyte F., Barrow M.P., O'Connor P.B.,

Chem Commun (Camb) 54:13853-13856(2018)

Nucleation of beta-rich oligomers and beta-barrels in the early aggregation of human islet amyloid polypeptide.

Sun Y., Kakinen A., Xing Y., Pilkington E.H., Davis T.P., Ke P.C., Ding F.,

Biochim Biophys Acta Mol Basis Dis 1865:434-444(2019)

Patatin-like phospholipase domain containing 3-gene (adiponutrin), preptin, kisspeptin and amylin regulates oocyte developmental capacity in PCOS.

Celik N., Aydin S., Ugur K., Yardim M., Acet M., Yavuzkir S., Sahin I., Celik O.,

Cell Mol Biol (Noisy-le-grand) 64:7-12(2018)

Copper ions induce dityrosine-linked dimers in human but not in murine islet amyloid polypeptide (IAPP/amylin).

Dong X., Svantesson T., Sholts S.B., Wallin C., Jarvet J., Graslund A., Warmlander S.K.T.S.,

Biochem Biophys Res Commun 510:520-524(2019)

All-atom structure ensembles of islet amyloid polypeptides determined by enhanced sampling and experiment data restraints.

Su X., Wang K., Liu N., Chen J., Li Y., Duan M.,

Proteins 87:541-550(2019)

Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.

Gejyo F., Homma N., Suzuki Y., Arakawa M.,

N Engl J Med 314:585-586(1986)

Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic beta-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity.

Dubey R., Patil K., Dantu S.C., Sardesai D.M., Bhatia P., Malik N., Acharya J.D., Sarkar S., Ghosh S., Chakrabarti R., Sharma S., Kumar A.,

Biochem J 476:889-907(2019)

Assignment of the human and mouse prion protein genes to homologous chromosomes.

Sparkes R.S., Simon M., Cohn V.H., Fournier R.E., Lem J., Klisak I., Heinzmann C., Blatt C., Lucero M., Mohandas T.,

Proc Natl Acad Sci U S A 83:7358-7362(1986)

IAPP toxicity activates HIF1alpha/PFKFB3 signaling delaying beta-cell loss at the expense of beta-cell function.

Montemurro C., Nomoto H., Pei L., Parekh V.S., Vongbunyong K.E., Vadrevu S., Gurlo T., Butler A.E., Subramaniam R., Ritou E., Shirihai O.S., Satin L.S., Butler P.C., Tudzarova S.,

Nat Commun 10:2679-2679(2019)

Revealing a Dual Role of Ganglioside Lipids in the Aggregation of Membrane-Associated Islet Amyloid Polypeptide.

Christensen M., Schiott B.,

J Membr Biol 252:343-356(2019)

Isolation and characterization of the human Gs alpha gene.

Kozasa T., Itoh H., Tsukamoto T., Kaziro Y.,

Proc. Natl. Acad. Sci. U.S.A. 85:2081-2085(1988)

Amylin as a potential link between type 2 diabetes and alzheimer disease.

Martinez-Valbuena I., Valenti-Azcarate R., Amat-Villegas I., Riverol M., Marcilla I., de Andrea C.E., Sanchez-Arias J.A., Del Mar Carmona-Abellan M., Marti G., Erro M.E., Martinez-Vila E., Tunon M.T., Luquin M.R.,

Ann Neurol 86:539-551(2019)

Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.

Nichols W.C., Dwulet F.E., Liepnieks J., Benson M.D.,

Biochem. Biophys. Res. Commun. 156:762-768(1988)

Molecular Dynamics Simulations Reveal the Inhibitory Mechanism of Dopamine against Human Islet Amyloid Polypeptide (hIAPP) Aggregation and Its Destabilization Effect on hIAPP Protofibrils.

Lao Z., Chen Y., Tang Y., Wei G.,

ACS Chem Neurosci 10:4151-4159(2019)

3D analysis of human islet amyloid polypeptide crystalline structures in Drosophila melanogaster.

Xie L., Gu X., Okamoto K., Westermark G.T., Leifer K.,

PLoS One 14:e0223456-e0223456(2019)

Pro-islet amyloid polypeptide in micelles contains a helical prohormone segment.

DeLisle C.F., Malooley A.L., Banerjee I., Lorieau J.L.,

FEBS J 287:4440-4457(2020)

Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-beta fibrils.

Roder C., Kupreichyk T., Gremer L., Schafer L.U., Pothula K.R., Ravelli R.B.G., Willbold D., Hoyer W., Schroder G.F.,

Nat Struct Mol Biol 27:660-667(2020)

Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils.

Cao Q., Boyer D.R., Sawaya M.R., Ge P., Eisenberg D.S.,

Nat Struct Mol Biol 27:653-659(2020)

Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.

Benson M.D., Liepnieks J., Uemichi T., Wheeler G., Correa R.,

Nat. Genet. 3:252-255(1993)

Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition.

Myatt E.A., Westholm F.A., Weiss D.T., Solomon A., Schiffer M., Stevens F.J.,

Proc Natl Acad Sci U S A 91:3034-3038(1994)

Human lysozyme gene mutations cause hereditary systemic amyloidosis.

Pepy M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., Totty N., Nguyen O., Blake C.C.F., Terry C.J., Feest T.G., Zalin A.M., Hsuan J.J.,

Nature 362:553-557(1993)

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

Jarrett J.T., Berger E.P., Lansbury P.T. Jr.,

Biochemistry 32:4693-4697(1993)

beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.

Ahlgren U., Jonsson J., Jonsson L., Simu K., Edlund H.,

Genes Dev 12:1763-1768(1998)

Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor.

Baker L.P., Nielsen M.D., Impey S., Metcalf M.A., Poser S.W., Chan G., Obrietan K., Hamblin M.W., Storm D.R.,

J Biol Chem 273:17469-17476(1998)

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease.

El-Agnaf O.M., Jakes R., Curran M.D., Wallace A.,

FEBS Lett 440:67-70(1998)

Synonyms

Description

KO Status

Drug Information

Allogeneic human islets of Langerhans (University of Illinois)

Nirogacestat

Bisnorcymserine

NI-203

Caprospinol

AC-187

Phenserine tartrate

BI-473494

ACO-253

AC-625

References

The complete islet amyloid polypeptide precursor is encoded by two exons

Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history

An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing

The human islet amyloid polypeptide (IAPP) gene. Organization, chromosomal localization and functional identification of a promoter region

Islet amyloid polypeptide: structure and upstream sequences of the IAPP gene in rat and man

Characterization of the human islet amyloid polypeptide/amylin gene transcripts: identification of a new polyadenylation site

Cloning and expression of human islet amyloid polypeptide in cultured cells

Islet amyloid polypeptide: identification and chromosomal localization of the human gene

Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus